Log in
Enquire now
‌

US Patent 11903934 Rifabutin treatment methods, uses, and compositions

Patent 11903934 was granted and assigned to BioVersys AG on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
BioVersys AG
BioVersys AG
0
Current Assignee
BioVersys AG
BioVersys AG
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119039340
Patent Inventor Names
Sergio Lociuro0
Glenn E. Dale0
Marilyne Bourotte0
Stefano Biondi0
Marc Gitzinger0
Date of Patent
February 20, 2024
0
Patent Application Number
178268170
Date Filed
May 27, 2022
0
Patent Primary Examiner
‌
Benjamin J Packard
0
CPC Code
‌
A61K 31/438
0
Patent abstract

The invention provides formulations containing highly concentrated solutions of rifabutin and methods of making such formulations. The invention also provides methods of using such formulations to treat a bacterial infection in a subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11903934 Rifabutin treatment methods, uses, and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.